Brochure download

information we require

please check before submitting



Unfortunately the document is not available at this current time, however if you leave your details we'll get it to you as soon as we can.

Please fill in all the information requested. It is very important you enter this information correctly so we can contact you with the document.

Privacy statement »

Manage your email preferences »

Remember my details Information

Information
Remember my details
We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details

 

Our Story

 

 

ENQUIRE TO SPONSOR

 

The Future of Advanced Therapies


The Advanced Therapies Congress is Europe’s largest commercial cell and gene therapy conference and exhibition. The event is for the leaders of pioneering ATMP companies and their most senior executives in charge of the latest tech and strategies that are driving the industry forward.


With 10 tracks of content, the agenda covers everything from manufacturing, supply chain & logistics, pricing & market access, to developments in key therapeutic areas; cell therapy, gene therapy, gene modified cell therapy, immunotherapy, and much more.

 

DOWNLOAD PROSPECTUS

Advanced Therapies 2026 will feature

 

To unite advanced therapies leaders from across the world, to give insight and to promote collaboration to accelerate the development & commercialisation of next generation medicines, bring them to market and help change patient lives.


For the past 20 years, the Advanced Therapies Congress has evolved and grown into the leading cell and gene conference and exhibition globally, with hundreds of speakers, thousands of attendees and hundreds of networking opportunities.

300 expert speakers
10 tracks
100 sponsors
100 start-ups & 100 posters
2500+ attendees
Smart AI assisted networking
One to one meetings
More: Roundtables, panels, workshops, opportunities to meet face to face

 

“High quality speakers, both in scientific/industrial content and the level of speaker sent in to speak - often CSO/CEO. I also appreciated the quality of the companies with stalls and the variation of startup companies to speak with”

Head of Development, Micregen

“It was a great event for anyone in ATMPs. ”

Managing Director, INDICRO Ltd

“Well organized, good turnout, talks of interest for people in the field, a good mix of service and solutions providers."

Chief Scientific Officer, Biointaxis S.L.

“Plenty of engaging talks, well laid out and easy to navigate both between talks and also to make your way through the stalls and displays. The terrapin app also works really well and I had many great conversations with stall holders.”

Cell Therapy Production Supervisor, Anthony Nolan

“Really interactive sessions, lot of commercial booths to discuss with product specialists, well structured talks organisation with focused sessions."

Senior Scientist, Orchard Therapeutics

“It was a great event. Was able to make good connections entrepreneurs, CROs, CDMOs and amazing scientist. Excellent mixture of startups, commercial and science.”

Executive Director, Aila Biotech

"Meeting remains a very nice forum to engage and exchange with our peers in CGT;. Great people and content and lots of opportunities to dialog with experts on our sector."

President and Chief Executive Officer, Co-Founder, NKILT Therapeutics Inc.

London & The UK

London has a long history as a centre for advancement in medicine and biology and today, together with Oxford and Cambridge, forms the ‘Golden Triangle’, a global hub for life sciences. Across the UK, there are 6,300 life sciences businesses, generating an £80.7bn turnover, and employing more than 256,000 people.

There are over 130 advanced therapies companies in the UK, with 60% residing in the greater southeast of England, including university spinouts such as Orchard Therapeutics, Autolus, Cell Medica, GammaDelta Therapeutics and Astellas.

London benefits from excellence and expertise within academia, industry and the National Health Service (NHS) and is a dynamic hub for spinouts, scaling companies and investment.

Home to world-leading universities, hospitals and an expansive patient pool, the region is a growing engine room for translational and experimental medicine, with several National Institute for Health Research (NIHR) Biomedical Research Centres sitting between academia and the NHS and three of England’s Academic Health Sciences Centres.